Territory Sales Executive

Hereditary Cancers, North West

Posted on 5/30/2024



1,001-5,000 employees

AI-enabled precision medicine and analytics

AI & Machine Learning
Data & Analytics


Seattle, WA, USA

Required Skills
  • B.S. in life science, biology, business, or marketing - MBA preferred
  • 3+ years of direct account management experience in a molecular diagnostic setting
  • 5+ years of experience working with major cancer centers and clinics, oncology GPO’s, large health systems, IHDN’s, and large oncology practices
  • Demonstrated measurable revenue generation at a diagnostic, pharmaceutical, or relevant biotechnology company
  • Drive strategic business expansion/collaboration opportunities with major U.S. cancer centers and clinics, Top 20 largest oncology practices in the territory, Key Opinion Leaders (KOLs), and Academic Medical Centers (AMCs)
  • Structure detailed strategic plans for gaining and retaining new and existing clients
  • Maximize client-bill contracting opportunities
  • Implement laboratory services agreements (LSA’s) with bill account institutions
  • Collaborate and coordinate with all sales positions to ensure successful attainment of company goals
  • Identify and develop partnering opportunities between prospective oncology clients and Tempus
  • Promote and drive compliance with new web-based molecular information tools for all clients
  • Continually analyze competitive landscape and environment within assigned accounts
  • Monitor performance of sales to ensure objectives are met
  • Develop and implement a comprehensive business plan for the territory
  • Work effectively with individuals across multiple departments throughout Tempus
  • Embrace, embody, and represent the Tempus company culture at all times to external and internal constituents

Tempus specializes in AI-enabled precision medicine, utilizing data and artificial intelligence to accelerate the discovery of novel targets, predict treatment effectiveness, identify clinical trials, and diagnose diseases earlier. The company's analytical machine learning platform leverages expansive clinical and molecular data to enable real-time, data-driven decisions for personalized care and targeted therapies.

Company Stage

Series G

Total Funding



Chicago, Illinois



Growth & Insights

6 month growth


1 year growth


2 year growth